Abstract
The CD40 molecule, a member of the TNF receptor gene family, has been intensively studied with respect to regulation of B cell proliferation and survival. Although CD40 is also expressed on carcinoma cell lines, information concerning the biological function of CD40 on cells of epithelial origin is limited. In this study we detected constitutive CD40 on human breast carcinoma cell lines and an increase in CD40 expression following treatment with cytokines IL-1α and IFN-γ. CD40 ligation was also found to increase MHC II expression in cells pretreated with IFN-γ. In contrast to normal B cells, where CD40 signaling provides a potent survival signal, we observed that CD40 ligation in breast carcinoma cells results in growth inhibition and enhanced susceptibility to Fas-mediated apoptosis. Enhanced apoptosis appears to be attributable, at least in part, to an up-regulation of Fas expression caused by CD40 ligation. These results suggest a potentially important role for CD40 in breast tumor biology.
Similar content being viewed by others
References
Cleveland JL, Ihle JN: Contenders in FasL/TNF death signaling. Cell 81: 479–482, 1995
Baker SJ, Reedy EP: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12: 1–9, 1996
Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959–962, 1994
Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243, 1991
Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845–853, 1993
Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8: 1403–1410, 1989
Hess S, Englemann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 183: 159–167, 1996
Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJO, Reed JC, Kiefl E, Young LS: CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13: 2243–2254, 1996
Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC: Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bel-2 induction. Eur J Immunol 23: 2368–2371, 1993
Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, Covey LR, Lee JJ, Rothman P, Chess L: T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype Switch recombination and rescues B cells from programmed cell death. J Immunol 152: 2163–2171, 1994
Lens SM, Tessclaar K, den Drijver BFA, van Ocrs MHJ, van Lier RAW: A dual role for both CD40-ligand and TNF-α in controlling human B cell death. J Immunol 156: 507–514, 1996
Banchereau J, de-Paoli P, Valle A, Garcia E, Rousset F: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251: 70–72, 1991
Jumper MD, Nishioka Y, Davis LS, Lipsky PE, Meek K: Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands. J Immunol 155: 2369–2378, 1995
Jabara HH, Fu SM, Geha RS, Vercelli D: CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 172: 1861–1864, 1990
Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal leukemic B cells through a CD40-dependent signal. J Exp Med 177: 925–935, 1993
Roy M, Aruffo A, Ledbetter J, Linsley P, Kehry M, Noelle R: Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 25: 596–603, 1995
O'Doherty U, Steinman RM, Peng M, Cameron PU, Gezelter S, Kopeloff I, Swiggard WJ, Pope M, Bhardwaj M: Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 178: 1067–1076, 1993
Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G: Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol 25: 1943–1950, 1995
Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178: 669–674, 1993
Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipps RP: CD40 expression by human fibroblasts. Clin Immunol Immunopathol 77: 42–51, 1995
Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92: 4342–4346, 1995
Young LS, Dawson CW, Brown KW, Rickinson AB: Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 43: 786–794, 1989
Galy AH, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149: 775–782, 1992
Paulic S, Ehlin-Hcnriksson B, Melistedt H, Koho H, Ben-Aissa H, Perlmann P: A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20: 23–28, 1985
Paulie S, Rosen A, Ehlin-Henriksson B, Braesch-Anderson S, Jakobson E, Koho H, Perlmann P: The human B lymphocyte and carcinoma antigen, CD40, is a phosphoprotein involved in growth signal transduction. J Immunol 142: 590–595, 1989
Koho H, Paulie S, Ben-Aissa H, Jonsdottir I, Hansson Y, Lundblad ML, Perlmann P: Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol Immunother 17: 165–172, 1984
Brodie C, Gelfand EW: Regulation of immunoglobulin production by nerve growth factor: Comparison with anti-CD40. J Neuroimmunol 52: 87–96, 1994
Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 89: 6550–6554, 1992
Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC: Presence of a new conserved domain in CART1, a novel member of the Tumor Necrosis Factor Receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 270: 25715–25721, 1996
Guardiola J, Maffei A: Control of MHC class II gene expression in autoimmune, infectious, and neoplastic disease. Crit Rev Immunol 13: 247–268, 1993
Sharpe JC, Abel PD, Gilbertson JA, Brawn P, Foster CS: Modulated expression of human leukocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium. Br J Urol 74: 609–616, 1994
Blades RA, Keating PJ, McWilliam LJ, George MJR, Stern PL: Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology 46: 681–687, 1995
Hasbold J, Johnson Leger C, Atkins CJ, Clark EA, Klaus GGB: Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur J Immunol 24: 1835–1842, 1994
Lu Y, Ussery GD, Muncaster MM, Gallic BL, Blanck G: Evidence for retinoblastoma protein (RB) dependent and independent IFN-γ responses: RB coordinately rescues IFN-γ induction of MHC class II gene transcription in noninducible breast carcinoma cells. Oncogene 9: 1015–1019, 1994
Keane MM, Etterberg SA, Lowrey GA, Russell EK, Lipkowitz S: Fas expression and function in normal and malignant breast cell lines. Cancer Res 56: 4791–4798, 1996
Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P: Constitutive and induced expression of apo-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and malignant cells. Lab Invest 69: 415–429, 1993
Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182: 1557–1565, 1995
Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182: 1265–1273, 1995
Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC: Expansion or elimination of B cells in vivo: Dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319–329, 1996
Cromme FV, Van-Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 69: 1176–1181, 1994
Baskar S, Azarenko V, Garcia-Marshall E, Hughes E, Ostrand-Rosenberg S: MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice. Cell Immunol 155: 123–133, 1994
Hock RA, Reynolds BD, Tucker-McClung CL, Kowk WW: Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors. J Immunother Emphasis Tumor Immunol 17: 12–18, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wingett, D.G., Vestal, R.E., Forcier, K. et al. CD40 is functionally expressed on human breast carcinomas: Variable inducibility by cytokines and enhancement of Fas-mediated apoptosis. Breast Cancer Res Treat 50, 27–36 (1998). https://doi.org/10.1023/A:1006012607452
Issue Date:
DOI: https://doi.org/10.1023/A:1006012607452